Home > Insider Trading > Filing (0001867096-25-000123)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1867096	Xeris Biopharma Holdings Inc.	XERS	Pharmaceutical Preparations (2834)	871082097

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2031695	Kevin Mcculloch	C/O Xeris Biopharma Holdings, Inc. 1375 West Fulton Street, Suite 1300 Chicago IL 60607	See Remarks	No	Yes	No	No

Transaction Summary

Number of Shares After Transactions:	1,701,159 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-08-01	14,651	$5.38	1,701,159	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	F	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	25,000	Indirect	By Spouse
Common Stock	2,000	Indirect	By Charles R. McCulloch Trust dated 1990

Footnotes

Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of August 1, 2025.
These shares include 7,225 shares that were purchased on June 30, 2025 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan.
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.